Welcome to the official website of Unipharm pharmaceutical industry Co., Ltd.！
Focus on research and development of new active pharmaceutical ingredients, pharmaceutical intermediates, APIs and other specialty chemicals
Pharmaceutical Intermediates Heterocyclic Block Organic Block
Home> Pharmaceutical Intermediates>Antineoplastic Agents> Tahilis Intermediate
Tahilis (Gdc-032) Is An Experimental Cancer Drug Developed By Roche Company. It Is A Small Molecule Inhibitor Targeting Phosphatidylinositol 3-Kinase Subtype Pik3Ca.
Ethylene carbonate
UP26024408096-49-1
9-bromo-5,6-dihydrobenzo[f]imidazo[1,2-d][1,4]oxazepine
UP5132583411282516-67-9
